These results indicate that the high expression of RORC is correlated with better survival in multiple cancers, the high expression of RORC is inversely associated with the expression of co-inhibitory immune checkpoints, and high IL-17A is associated with high tumor infiltration of CD8+ T cells. Here, RORC is linked to neoplasm.